Abstract
Edema and lethal toxins represent two of the main virulence factors of Bacillus anthracis. They are formed by three components: protective antigen (PA, the binding component), edema factor (EF), and lethal factor (LF) that can associate to give lethal toxin (LT) and edema toxin (ET). EF and LF bear the activity, which are an adenylate cyclase and a metalloprotease, respectively. During the last two decades, numerous studies have improved our knowledge about the biochemical effects of these toxins.
The main biochemical effects of the toxins are presented first, describing how the toxins enter target cells through binding with receptors and are finally delivered to the cytosol. In a second section, the critical targets of the toxins, during the early and late stages of the infection, are discussed.
Similar content being viewed by others
References
Abrami L, et al. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol. 2003;160(3):321–8.
Abrami L, et al. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J Cell Biol. 2004;166(5):645–51.
Abrami L, et al. Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6. Cell Microbiol. 2008;10(12):2509–19.
Abrami L, Kunz B, van der Goot FG. Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. Proc Natl Acad Sci U S A. 2010a;107(4):1420–4.
Abrami L, et al. Endocytosis of the anthrax toxin is mediated by clathrin, actin and unconventional adaptors. PLoS Pathog. 2010b;6(3):e1000792.
Abrami L, et al. Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin. Cell Rep. 2013;5(4):986–96.
Abramova FA, et al. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90(6):2291–4.
Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet. 2006;38(2):240–4.
Boyer AE, et al. Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax. J Infect Dis. 2011;204(9):1321–7.
Bradley KA, et al. Identification of the cellular receptor for anthrax toxin. Nature. 2001;414(6860):225–9.
Cleret A, et al. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J Immunol. 2007;178(12):7994–8001.
Cleret-Buhot A, et al. Both lethal and edema toxins of Bacillus anthracis disrupt the human dendritic cell chemokine network. PLoS One. 2012;7(8):e43266.
Corre JP, et al. In vivo germination of Bacillus anthracis spores during murine cutaneous infection. J Infect Dis. 2013;207(3):450–7.
Cote CK, et al. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Microb Pathog. 2005;38(5–6):209–25.
Cui X, et al. Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis. 2007;195(4):572–80.
Dumetz F, et al. Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol. 2011;178(6):2523–35.
Duong S, Chiaraviglio L, Kirby JE. Histopathology in a murine model of anthrax. Int J Exp Pathol. 2006;87(2):131–7.
Feld GK, Brown MJ, Krantz BA. Ratcheting up protein translocation with anthrax toxin. Protein Sci. 2012;21(5):606–24.
Firoved AM, et al. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol. 2005;167(5):1309–20.
Friedlander AM. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem. 1986;261(16):7123–6.
Friedlander AM, et al. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect Immun. 1993;61(1):245–52.
Ghosh CC, et al. Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthrax. Proc Natl Acad Sci U S A. 2012;109(25):10024–9.
Gnade BT, et al. Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions. Toxins (Basel). 2010;2(7):1881–97.
Guarner J, et al. Pathology and pathogenesis of bioterrorism-related inhalational anthrax. Am J Pathol. 2003;163(2):701–9.
Guichard A, et al. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature. 2010;467(7317):854–8.
Guichard A, Nizet V, Bier E. New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes Infect. 2012;14(2):97–118.
Hicks CW, et al. An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med. 2012;38(7):1092–104.
Hong J, et al. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J Biol Chem. 2007;282(27):19781–7.
Jelacic TM, et al. Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells. Infect Immun. 2014;82(8):3405–16.
Jiang J, et al. Atomic structure of anthrax protective antigen pore elucidates toxin translocation. Nature. 2015;521(7553):545–9.
Kintzer AF, et al. The protective antigen component of anthrax toxin forms functional octameric complexes. J Mol Biol. 2009;392(3):614–29.
Klezovich-Benard M, et al. Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog. 2012;8(1):e1002481.
Kuo SR, et al. Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage. Microb Pathog. 2008;44(6):467–72.
Lehmann M, et al. Lung epithelial injury by B. anthracis lethal toxin is caused by MKK-dependent loss of cytoskeletal integrity. PLoS One. 2009;4(3):e4755.
Leppla SH. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A. 1982;79(10):3162–6.
Liu S, et al. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A. 2009;106(30):12424–9.
Liu S, et al. Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe. 2010;8(5):455–62.
Liu S, et al. Key tissue targets responsible for anthrax-toxin-induced lethality. Nature. 2013;501(7465):63–8.
Liu S, Moayeri M, Leppla SH. Anthrax lethal and edema toxins in anthrax pathogenesis. Trends Microbiol. 2014;22(6):317–25.
Maddugoda MP, et al. cAMP signaling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerization. Cell Host Microbe. 2011;10(5):464–74.
Makino S, et al. Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J Infect Dis. 2002;186(2):227–33.
Martchenko M, Jeong SY, Cohen SN. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin. Proc Natl Acad Sci U S A. 2010;107(35):15583–8.
Mayer-Scholl A, et al. Human neutrophils kill Bacillus anthracis. PLoS Pathog. 2005;1(3):e23.
Miller CJ, Elliott JL, Collier RJ. Anthrax protective antigen: prepore-to-pore conversion. Biochemistry. 1999;38(32):10432–41.
Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Asp Med. 2009;30(6):439–55.
Moayeri M, et al. Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest. 2003;112(5):670–82.
Moayeri M, et al. Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin. Infect Immun. 2005;73(7):4238–44.
Moayeri M, Wiggins JF, Leppla SH. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect Immun. 2007;75(11):5175–84.
Moayeri M, et al. The heart is an early target of anthrax lethal toxin in mice: a protective role for neuronal nitric oxide synthase (nNOS). PLoS Pathog. 2009;5(5):e1000456.
Moayeri M, et al. Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog. 2010;6(12):e1001222.
Moayeri M, et al. Anthrax pathogenesis. Annu Rev Microbiol. 2015;69:185–208.
Mock M, Fouet A. Anthrax. Annu Rev Microbiol. 2001;55:647–71.
Ouyang W, et al. Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1alpha and causes decreased tolerance to hypoxic stress. J Biol Chem. 2014;289(7):4180–90.
Park JM, et al. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science. 2002;297(5589):2048–51.
Savransky V, et al. Pathology and pathophysiology of inhalational anthrax in a guinea pig model. Infect Immun. 2013;81(4):1152–63.
Sun C, et al. Anthrax lethal toxin disrupts intestinal barrier function and causes systemic infections with enteric bacteria. PLoS One. 2012;7(3):e33583.
Sun DS, et al. Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice. Virulence. 2015;6(5):466–75.
Tang WJ, Guo Q. The adenylyl cyclase activity of anthrax edema factor. Mol Asp Med. 2009;30(6):423–30.
Terra JK, et al. Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol. 2010;184(1):17–20.
Tonello F, Montecucco C. The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity. Mol Asp Med. 2009;30(6):431–8.
Tournier JN, et al. Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Mol Asp Med. 2009;30(6):456–66.
Trescos Y, et al. Micropatterned macrophage analysis reveals global cytoskeleton constraints induced by Bacillus anthracis edema toxin. Infect Immun. 2015;83(8):3114–25.
Vasconcelos D, et al. Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). Lab Investig. 2003;83(8):1201–9.
Vitale G, et al. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun. 1998;248(3):706–11.
Warfel JM, Steele AD, D’Agnillo F. Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol. 2005;166(6):1871–81.
Wei W, et al. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell. 2006;124(6):1141–54.
Welkos SL, Friedlander AM. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog. 1988;4(1):53–69.
Young JA, Collier RJ. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem. 2007;76:243–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media B.V.
About this entry
Cite this entry
Trescos, Y., Rougeaux, C., Tournier, JN. (2018). Bacillus anthracis Toxins: Efficient Biochemical Weapons for the Infectious Battle. In: Stiles, B., Alape-Girón, A., Dubreuil, J., Mandal, M. (eds) Microbial Toxins. Toxinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6449-1_8
Download citation
DOI: https://doi.org/10.1007/978-94-007-6449-1_8
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6448-4
Online ISBN: 978-94-007-6449-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences